SEC Company Response from Life Technologies Corp (CIK 0001073431) — Dec 9, 2004
Life Technologies Corp (CIK 0001073431)
Date: Dec. 9, 2004 · CIK: 0001073431 · Accession: 0001193125-04-210040
AI Filing Summary & Sentiment
File numbers found in text: 333-120330
Letter
United States Securities and Exchange Commission Mail Stop 0303 Washington, D.C. 20549 Re: Invitrogen Corporation Amendment No. 2 to Registration Statement on Form S-4 (File No. 333-120330)
Dear Mr. Panos:
On behalf of Invitrogen Corporation, I hereby request that the Commission take appropriate action to make the above-captioned Registration Statement effective at 9:00 a.m. Washington, D.C. Time, on December 9, 2004, or as soon thereafter as practicable. Invitrogen acknowledges that:
• should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
• the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
• the company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Thank you for your assistance.
Sincerely,
/s/ John A.
Cottingham
Show Raw Text
CORRESP 1 filename1.htm Acceleration Request Invitrogen Corporation 1600 Faraday Avenue PO Box 6482 Carlsbad, California 92008 December 8, 2004 VIA FACSIMILE (202) 942-9638 AND EDGAR Mr. Nicholas P. Panos, Esq. United States Securities and Exchange Commission 450 Fifth Street, N.W. Mail Stop 0303 Washington, D.C. 20549 Re: Invitrogen Corporation Amendment No. 2 to Registration Statement on Form S-4 (File No. 333-120330) Dear Mr. Panos: On behalf of Invitrogen Corporation, I hereby request that the Commission take appropriate action to make the above-captioned Registration Statement effective at 9:00 a.m. Washington, D.C. Time, on December 9, 2004, or as soon thereafter as practicable. Invitrogen acknowledges that: • should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; • the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and • the company may not assert this action as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Thank you for your assistance. Sincerely, /s/ John A. Cottingham John A. Cottingham Senior Vice President, General Counsel and Secretary cc: Paul B. Johnson, Esq. Marty B. Lorenzo, Esq.